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Summary
Chediak-Higashi Syndrome (CHS) is an autosomal recessive disease affecting secretory granules
and lysosome-like organelles . In CHS fibroblasts, acidic organelles are abnormallylarge and clustered
in the perinuclear area . We have analyzed fibroblast cell lines from a CHS patient and from the
murine model for CHS, the beige mouse, to determine which lysosome-like compartments are
affected. Uptake of neutral red showed that in both beige and CHS cell lines, the acidic organelles
were markedly clustered in the perinuclear region of the cells . Giant organelles (>4 gm) were
observed in a fraction of the cells, and these were more dramatic in the beige fibroblasts than
in theCHS fibroblasts . The total dye uptake of both mutant cell lines was similar to their respective
wild type fibroblasts, suggesting that the overall volume of acidic compartments is unaffected
by the disorder. Histochemistry and immunofluorescence showed that the giant organelles in
both beige and CHS fibroblasts were positive for cathepsin D, lysosome-associated membrane
protein (LAMP) 1, LAMP 2, and a 120-kD lysosomal glycoprotein, all marker proteins for late
endosomes and lysosomes . The giant organelles were also negative for transferrin receptor and
mannose-6-phosphate receptor, and most of them were also negative for rab 7 . This distribution
of marker proteins shows that the giant organelles in both beige and CHS are derived from late
compartments of the endocytic pathway. This conclusion was confirmed using endocytic tracers .
BSA was transported to the giant organelles, but only after long incubation times, and only
at 37°C. ate-Macroglobulin was taken up and degraded at similar rates by CHS or beige cells
and their respective wild type control cells. Taken together, our results indicate that the mutation
inCHS specifically affects late endosomes and lysosomes, with little or no effect on early endosomes.
Although the mutation clearly causes mislocalization of these organelles, it appears to have little
effect on their endocytic and degradative functions.
C
hediak-Higashi Syndrome (CHS)l is a rare autosomal
recessive disorder in humans, affecting multiple cell
lineages andcommonly classified as a lysosomal abnormality
(1) . Analogous disorders have been identified in a variety of
species (2-4), the best studied of which is the beige mouse
(5, 6) . CHS patients suffer from dilution of skin pigmenta-
tion, severe recurrent infections, lymphoproliferative disorder
and progressive peripheral neuropathy, reflecting the range
of affected cells (7) . Many of the clinical manifestations can
be attributed to abnormalities in leukocyte function, and several
hemopoietic lineages, including neutrophils and cytolytic lym-
1 Abbreviations used in this paper . CD-MPR, cation-dependent (46 kD)
mannose-6-phosphate receptor ; CHS, Chediak-Higashi syndrome ; CI-
MPR, cation-independent (300 kD) mannose-6-phosphate receptor; DTAF,
dichlorotirazinylamino-fluorescein; LAMP, lysosome-associated membrane
protein; lgp-120, 120-kD lysosomal glycoprotein; a2M, a2-macroglobu-
lin ; NM1, normal mouse 1 .
phocytes, have been shown to be functionally defective in CHS
and in beige (8-13) .
At the cellular level CHS is characterized by the presence
of giant organelles . There is, however, considerable diversity
and tissue specificity in the nature of these giant organelles ;
secretory organelles are enlarged in some cell types while en-
docytic organelles are affected in others (6, 8, 12) . Neutro-
phils, platelets, eosinophils, mast cells, and cytolytic lympho-
cytes from CHS patients, all cells that normally engage in
regulated secretion, contain massive secretory granules. In each
case, the enlarged secretory granule retains its characteristic
ultrastructure and protein composition . In nonsecretory cell
types, such as monocytes and fibroblasts, the enlarged or-
ganelles are lysosome-like. Thus, the histological classification
ofCHS betrays a complex range ofaffected cellular organelles.
The giant organelles in CHS and beige cells are often de-
scribed as lysosomes, but this definition is largely based on
classical histochemical criteria (6, 8) . In recent years, how-
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that stain the giant organelles, such as neutral red and acri-
dine orange, are not exclusive markers for lysosomes. It is
now known that coated and uncoated vesicles, early endo-
somes, late endosomes, and lysosomes are all acidified to
varying degrees and therefore all can accumulate these dyes
(14) . Similarly, acid phosphatase, a "lysosomal marker" found
in the giant organelles, is known to have a broader intracel-
lular distribution (15, 16) .
Recentwork on the endorytic pathway has resulted in the
characterization of several marker proteins that distinguish
more definitively among distinct endocytic compartments .
Several membrane spanning proteins are now known to re-
side insome but not all of the endorytic compartments . The
transferrin receptor cycles between the plasmamembrane and
early endosomes (17) ; the cation-independent and cation-
dependent mannose-6-phosphate receptors (CI- andCD-MPR)
are found in late endosomes but not in mature lysosomes (18),
whereas the lysosome-associated membrane proteins (LAMPs)
and 120-kD lysosomal glycoprotein (Igp-120) (19, 20) reside
in both late endosomes and lysosomes . Much has also been
learned about how both soluble lysosomal enzymes and
membrane-spanning glycoproteins are targeted to lysosomes,
and conditions have been defined that block movement be-
tween endocytic compartments (21, 22) . Finally, small GTP
binding proteins from the rab family have been shown to
be involved in vesicle fusion along the endocytic pathway and
to interact specifically with distinct endocytic compartments
(23) . In light of all this new information, it was interesting
to ask more precisely whether the CHS and beige mutations
affect a defined endocytic compartment, and if so, whether
the same compartment is affected in both humans and mice.
Recent clinical advances in treating CHS patients center
around bone marrow transplantation, replacing only hemo-
poietic cells. As survival times of patients increase, under-
standing the effects of the CHS defect on other cells will
be important for predicting and treating abnormalities in other
tissues . Therefore, in this study we focused on defining the
defect in fibroblasts . By better understanding which endo-
cytic compartments are affected in these cells, we seek to de-
velop a unifying explanation for the effects of the disease on
endocytic organelles and secretory granules in various cell types.
Materials and Methods
Cells.
￿
GM02075A is a skin fibroblast cell line, derived from
an 18-mo-old female with clinical symptoms of Chediak-Higashi
Syndrome, and was obtained from theHuman Genetic Mutant Cell
Repository (Camden, NJ) . The human control skin fibroblast line,
CCD-45Sk, was derivedfrom a 3-mo-old female, and obtainedfrom
the American Type Culture Center (Rockville, MD) . The beige
and normal mouse (NMI) lines were derived from C57BL/6J-
BgJ and C57BL/6J mice, respectively (24), a generous gift ofDr.
T Lyerla (Clark University, Worcester, MA) . CCD-45Sk and
GM02075A were maintained in Dulbecco's minimal essential
medium supplemented with nonessential amino acids and 10-15%
FCS (both fromJRH Biosciences, Lenexa, KS), while the murine
lines were maintained inDulbecco's minimal essential medium sup-
plemented with 5% FCS .
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Antibodies.
￿
Antibody to the lysosomal glycoprotein lgp-120 was
a gift ofDr. I . Mellman (Yale University, New Haven, CT) ; 1D4B
monoclonal anti-mouse LAMPI and ABL93 anti-mouseLAMP
2 (20) were originally produced by Dr. T August (Johns Hopkins
University, Baltimore, MD) and obtained from the Developmental
Studies Hybridoma Bank ; rabbit anti-human LAMP1/2 antibody
was a kind gift of Dr. M . Fukuda (La Jolla Research Foundation,
La Jolla, CA); rabbit anti-cathepsin D sera were gifts of Dr. J .
Mort (McGill University, Montreal, Canada) and Dr.K . von Figura
(University ofGottingen, Germany) ; anti-MPR antisera were gifts
of Dr. W Brown (Cornell University, Ithaca, NY) and Dr. B.
Hoflack (EMBL, Heidelberg, Germany) . Rabbit anti-rab 7 and
monoclonal anti-rab 5 were gifts ofDr.M. Zerial (EMBL, Heidel-
berg, Germany) . Mouse mAb B3/25 anti-human transferrin
receptor was purchased from Boehringer Mannheim Corp., Indi-
anapolis, IN . The secondary antibodies used were : FITC-goat
anti-rabbit IgG (Sigma Chemical Co., St . Louis, MO) ; Texas red-
and FITC-goat anti-rat IgG (Jackson ImmunoResearch Labs, West
Grove, PA, and Rockland Inc ., Gilbertsville, PA) ; Texas red- and
Cy3-donkey anti-rabbit Ig (Jackson Labs) ; and FITC-goat
anti-mouse IgG (Southern Biotechnology, Birmingham, AL) .
Light Microscopy.
￿
Immunofluorescence studies were performed
as described previously (25) . Briefly, cells grown on coverslips were
fixed with 2% paraformaldehyde/PBS, quenched with 50 mM
NH4C1/PBS and permeabilized with PBS/0.01% saponin/0.25%
gelatin (PSG) . Coverslips were incubated for 1 h with primary an-
tibodies diluted appropriately in PSG, washed six times with PSG,
incubated 1 h with secondary antibody, and washed six times . Lo-
calization of rab proteins was performed essentially as described
in (23) . Cells were permeabilized before fixation by a 5-min incu-
bation with 0.03% saponin/80 mM Pipes, pH 7.2/1 mM
MgCIZ/5 mM EGTA, and then fixed with 2% paraformaldehyde
in PBS. Coverslips were mounted in 10% glycerol/PBS/2.5%
diazabicyclo-(2,2,2)octane, and observed using an Axiovert micro-
scope (Zeiss, Oberkochen, Germany) with a MRC-600 laser con-
focal attachment (Bio-Rad Inc., Richmond, CA) . Acid phospha-
tase cytochemistry was performed using the Sigma (St . Louis, MO)
kit according to the manufacturer'sinstructions, and visualized using
brightfield optics.
Uptake Studies.
￿
For neutral red staining, cells grown on cover-
slips were incubated for 30 min with 20-200 P,M neutral red in
PBS, washed three times rapidly in PBS, mounted in PBS, and ob-
served under phase contrast. For quantitation of neutral red up-
take, the cells were lysed in 1% Triton X-100/0 .1MHCl (26) and
the amount of dye was determined spectrophotometrically .
For fluorescence uptake studies, BSA was conjugated to
dichlorotriazinylamino-fluorescein (DTAF) . The molar ratio of
DTAF-BSA in the conjugate was 5-6 :1 . Cells were incubated with
5 mg/ml DTAF-BSA in complete medium for various times at 20°C
or 37°C, fixed, and either viewed directly, or processed as described
above for double-label immunofluorescence .
Electron Microscopy.
￿
BSA was conjugated to 12 urn gold parti-
cles (27), and fed to cells for various times at 37°C. The cells were
fixed on the Petri dish with 2% glutaraldehyde/0.15 M sodium
cacodylate, pH 7.4, 1mM CaC1 2 , scraped, and processed for elec-
tron microscopy as described previously (28), except that no staining
was done after sectioning.
Immunoblots .
￿
Cells were washed three times with balanced salt
solution and then lysed with buffer containing 1% NP-40 (25) .
Nuclei were pelleted and the postnuclear supernatants were sub-
jected to SDS-PAGE . After electrophoresis, the total cellular pro-
teins were transferred onto a nitrocellulose membrane (Amersham
Corp., Arlington Heights, IL) using a Hoefer apparatus and probed
Mutation in Beige CHS Affects Late Endosomes and Lysosomeswith antibodies as described previously (29) . The anti-human
LAMP1/2 antibody was used at 1:500 dilution anddeveloped using
"'I-protein A (Amersham Corp.) .
Uptake and Degradation of arMacroglobulin. Purified «2-
macroglobulin (a2M) was a generous gift of Drs. G. Salveson and
J. Enghild (from the Dept . ofPathology, Duke University, Durham,
NC) . The protein was treated with methylamine as in (30) to con-
vert it to the receptor-binding form, iodinated with the IodoBead
reagent (Pierce, Rockford, IL), and repurified by gel filtration . The
sp act was 9,000 cpm/ng . Binding of 1211-a?1vi to the cells was
completely inhibited by 100x excess of unlabeled azM . The up-
take studies were performed using the method of Maxfield et al .
(31) . Duplicate 35-mm plates ofcells (grown to subconfluency) were
deprived of serum for 1 h, allowed to bind 1211-a2M at 4°C for
1 h, washed at 4°C and then incubated for various times at either
4°C, 20°C, or 37°C . At the end of each time point, medium and
cells were separated, the cells were washed three times with cold
buffer, and then lysed with 0.5% NP-40 in PBS. TheTCA soluble
and precipitable cpm in each sample were then determined, to cal-
culate the extent of a2M degradation .
Results
Acidic Organelles Are Abnormally Distributed.
￿
The struc-
tural abnormality in beige cells and in CHS cells iscommonly
detected by visualizing the uptake ofthe dye neutral red, which
accumulates in acidic intracellular compartments. As shown
in Fig. 1B, uptake of neutral red by fibroblasts from amouse
homozygous for the beige mutation reveals a pattern that is
quite different from that observed with normal mouse fibro-
blasts . First, in comparison with normal fibroblasts, where
a significant number of neutral red-positive organelles are scat-
tered throughout the periphery (Fig. 1 A), the neutral-red
positive organelles in beige cells are much more clustered in
the perinuclear region and are almost completely excluded
from peripheral extensions (Fig. 1 B, arrowheads) . Second,
there is a dramatic variation in size of the neutral red-positive
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vesicles in beige fibroblasts. In addition to the normal-sized
structures, several giant organelles (3-4 jAm in diameter) can
be found in many cells . In normal fibroblasts the size distri-
bution of the neutral red-positive vesicles is much narrower,
and giant ones are seen only very rarely. Though the appear-
ance of the giant vesicles is the most dramatic aspect of the
beige phenotype, there is considerable cell-to-cell variation in
the number and size of the giant organelles. Furthermore,
we noticed that after prolonged incubation with neutral red
the size of the giant organelles increases. The perinuclear
clustering of all the neutral red-positive structures seems to
be a more consistent aspect of the beige phenotype (e.g., 2, 6) .
A similar phenotype is displayed by fibroblasts derived from
a CHS-patient (Fig. 1 D) . By comparison with a matched
line of normal human fibroblasts (Fig. 1 C), the neutral
red-positive vesicles in theCHS fibroblasts are strongly con-
centrated near the nucleus, and are virtually excluded from
peripheral extensions of the cell (Fig. 1 D, arrowheads) . In
addition, the average size of the acidic organelles is larger
than in the control cells. At least in the fibroblast line used
in this study, the appearance of exceptionally large organelles
(Fig. 1 D, arrow) was relatively rare; the clustered distribu-
tion and a moderate size increase were more characteristic
of the CHS cells.
It is clear from the distribution of neutral red in the beige
and CHS cells that both mutations result in the formation
ofacidic organelles that are fewer in number and larger than
normal . We therefore compared the total cellular uptake of
neutral red in the two mutant cell lines with that of their
matched control lines. Cells that had been incubated with
neutral red for 30 min were washed briefly, lysed in acidic
detergent solution (26), and their dye content measured spec-
trophotometrically. The total dye uptake by CHS and beige
cells was remarkably similar to that of their respective con-
trol cell lines (Table 1) . The total uptake of neutral red should
Figure 1 .
￿
Neutral red uptake by fibroblast cell
lines . Normal murine fibroblasts (A), beige mu-
rine fibroblasts (B), normal human fibroblasts (C)
and CHS human fibroblasts (D) were incubated
with neutral red for 30 min and viewed withDIC
optics. Note theperinuclear dustering and size vari-
ability of neutral red-positive organelles inBand
D as compared with A and C, respectively. Ar-
rowheads inB andDpoint to the cellboundaries.
(Anmu) A giant neutral red-positive organelle." Uptake studies were performed with either 20 or 200 uM input neu-
tral red . OD measurements were normalized to the lower input values,
since both concentrations were found to be in the linear range ofuptake .
t Number of separate experiments, each performed on triplicate plates .
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be proportional to the product of the total volume of acidic
compartments accessible to the dye and the acidity of those
compartments . In T lymphocytes, where we have used the
DAMP method (32) to determine thepH of individual lyso-
somes and endosomes, the beige mutation showed no effect
on thepH of either organelle (Hester, S ., J . Burkhardt and
Y Argon, unpublished data) . Assuming that the same is true
in beige and CHS fibroblasts, we surmise that the comparable
uptake of neutral red by the fibroblasts reflects comparable
overall volumes of the endosomal/lysosomal compartments .
Taken together, the results with neutral red show that the
acidic compartments in beige and CHS fibroblasts are normal
inpH and volume, but abnormal in their intracellular distri-
bution .
The Giant Organelles Contain Markersfor Late Endocytic Com-
partments.
￿
Since neutral red is taken up by many acidic or-
Mutation in Beige CHS Affects Late Endosomes and Lysosomes
Figure 2 .
￿
Distribution oflysosomal and endosomal
marker proteins in beige cells. Acid phosphatase (AcP)
was detected histochemically and observed using bright
field optics. CathepsinD (CatD), (LGP-120), and the
cation-independent mannose-6-phosphatase receptor
(MPR) were detected by confocal immunofluorescence
microscopy, as described in Materials and Methods.
Table 1 .
Cell
Quantitation of Neutral
A550/106 cells"
Red Uptake by
nt
Fibroblasts
Neutral red/
cell
fmol
Beige 4.187 ± 2.748 5 108 ± 71
NM1 3.810 ± 1 .469 4 100 ± 39
CHS 3.144 ± 0.809 4 75 ± 19
CCD 3.250 ± 1 .896 4 78 ± 43ganelles, we used specific marker proteins to determine more
precisely which compartments are affected in the beige and
CHS fibroblasts . Acid phosphatase, a hydrolase present in lyso-
somes and in endosomes, was detected histochemically (Fig.
2, A and B) . Most of the acid phosphatase-positive vesicles
were tightly clustered in the perinuclear region in beige cells,
whereas in normal fibroblasts they could be seen in periph-
eral processes . In the beige cells, numerous giant organelles
were acid phosphatase positive. Similar staining of clustered
organelles was obtained in the CHS fibroblasts (Fig. 3 B)
as compared with control human cells (Fig. 3 A) . Cathepsin
D, an endosomel/lysosomal hydrolase, which unlike acid phos-
phatase (16) bears the mannose-6-phosphate lysosomal tar-
geting signal, was localized by confocal immunofluorescence
microscopy. Although the anti-cathepsinD antibody labeled
small peripheral structures in addition to the giant organelles,
it was clear that the compartment affected by beige and CHS
contains this hydrolase (Figs . 2, C-D, and 3, C-D) .
Because these hydrolases reside in both endosomes and lyso-
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somes, we examined the distribution ofmembrane glycopro-
teins that have been used to distinguish between endosomes
and lysosomes (33) . The cation-independent mannose-6-
phosphatase receptor (CI-MPR) is present in early and late
endosomes, but is absent from mature lysosomes (18) . In con-
trast, members of the LAMP family of lysosomal glycopro-
teins, including LAMP1/lgp120 and LAMP2, are present in
late endosomes and lysosomes but absent from early endo-
somes (19, 20, 34) . As shown in Figs . 2 Fand 3 F, the giant
vesicles were LAMP-positive in both CHS and beige fibro-
blasts. Importantly, in both mutants the giant vesicles were
negative for CI-MPR (Figs. 2, G-H and 3, G-H) . Indeed,
they sometimes appeared as "negatively stained" structures,
made visible by the surrounding MPR-positive endosomes
(Fig . 2 H, arrowheads) . These results were confirmed using
four independent antibodies to theLAMP family ofproteins,
and three separate anti-CI-MPR antibodies (not shown) .
The distribution oftwo small GTP binding proteins was
also examined as a means of identifying the defective com-
Figure 3.
￿
Distribution of lysosomal and endosomal
marker proteins in CHS cells . The same histochem-
ical assay and antibodies as described inlegend to Fig.
2 were used on CHS and normal human fibroblasts,
with the substitution of the anti-human LAMMI/2
(LAMP) antibody as a lysosomal membrane glycopro-
tein marker.partment . Rab 5 and rab 7 have been shown to bind to early
and late endosomal compartments, respectively (35, 36, 23) .
When the distribution of these proteins was examined in the
beige and CHS fibroblasts, anti-rab 5 antibody did not stain
the giant perinuclear organelles (data not shown) . In con-
trast, anti-rab 7 antibody did label some giant organelles, as
well as other smaller structures (Fig. 4) . When double label
immunofluorescence was performed on normal mouse cells,
the distribution of rab 7 (Fig . 4 B) was a subset of the distri-
bution of LAMP-1 (Fig. 4 A) . This is in keeping with the
late endosomal localization of rab 7 in other cell types (35,
36, 23) . In beige cells, some of the large LAMP-positive struc-
tures were positive for rab 7 (Fig. 4, C-D, arrow), whereas
most were negative (Fig. 4, C-D, arrowheads) . Single labeling
of the human cells with anti-rab 7 revealed occasional giant
organelles and a clustered distribution in the CHS cells (Fig .
4 F) relative to wild type controls (Fig . 4 E) .
Finally, we tested the distribution ofthe transferrin receptor
as another criterion to distinguish between early and late en-
dosomes. Anti-transferrin receptor antibody gave a fine punc-
tate labeling pattern on all the cells tested . The giant organelles
were consistently negative for this marker of early endosomes
(data not shown) .
The presence of the hydrolases and lysosomal membrane
proteins in the giant organelles indicates that these structures
derive from late endosomal or lysosomal compartments . The
markers that usually distinguish late endosomes from lyso-
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somes, MPR, and rab 7, give somewhat conflicting results .
The absence ofCI-MPR from the giant organelles defines
them as mature lysosomes, but the presence of rab 7 on at
least some giant organelles marks these as more similar to
the late endosomal compartment .
The CHS Mutation Does Not Affect the Total Amount of
LAMP Family Proteins. The marker analysis showed that
the LAMP glycoproteins were the best markers for the
clustered giant organelles in both CHS and beige cells . The
staining with these antibodies was almost completely restricted
to the affected compartment . The fluorescence intensity was
very strong in the mutant cells with each of the anti-LAMP
antibodies tested, raising the possibility that these proteins
are overexpressed in beige and CHS cells. Western blot anal-
ysis was performed to test this possibility . Lysates were pre-
pared from CHS and control cells, and equivalent amounts
oflysate were compared bySDS-PAGE and immuno-blotting
with a rabbit serum that recognizesLAMPs 1 and 2 inhuman
cells (20) . Similar levels ofLAMP glycoproteins were detected
inCHS and control cell lines (Fig. 5) . Therefore, the apparent
increase in immunofluorescence intensity with antibodies to
LAMP family proteins must be due to concentration of these
proteins in the perinuclear region and the increased size of
the organelles, but not due to overexpression ofthese proteins .
The Giant Organelles Function As Late Endocytic Compart-
ments. Are the defective lysosomes/late endosomes still
capable of receiving endocytosed material, or are they off
Figure 4.
￿
Distribution of rab 7, a marker for
late endosomes. A and B, wild type mouse fibro-
blasts. C and D, beige fibroblasts. Each pair shows
cells doubly labeled with anti-LAMMI (rat MAb
1D4B) followed by Texas red goat anti-rat Ig (A
and C), and with rabbit anti-rab 7 followed by
FITC goat anti-rabbit Ig (B and D) . The arrows
in A and Bpoint to typical vesicular structures
in the wild type cells that are positive for both
markers . The arrows inC andDshow a giant or-
ganelle that is double labeled, whereas the arrow-
heads show a giant organelle that lacks rab 7 . (E)
Normal human fibroblasts labeled with anti-rab
7 followed by FITC goat anti-rabbit Ig; note the
disperse distribution. (F) CHS fibroblasts labeled
similarly; note the clustered distribution.Figure 5 .
￿
Comparison o£LAMP pro-
teinlevels inCHS and normal cells . Total
detergent lysates from CHS or control
fibroblasts were fractionated by SDS-
PAGE, transferred onto nitrocellulose
membrane, and probed with rabbit
anti-human LAMPI/2 serum, followed
by 1251-proteinA. (Lanes 1 and 3) Lysates
from 3 x 105 cells . (Lanes 2 and 4) Ly-
sates from 1 x 105 cells . The mobilities
of marker proteins are indicated at left .
pathway aberrant structures? To address this question, beige
cells were incubated with DTAF-conjugated BSA for 3 h at
37°C, chased overnight to load the lysosomal compartment
(37), and then fixed and counter-labeled with anti-1gp120 to
mark the giant organelles. When viewed by confocal micros-
copy, theDTAF-BSA had accumulated in various-sized vesicles,
including giant perinuclear structures (Fig . 6 A) that were
rimmed with 1gp120 (Fig . 6 B) . DTAF-BSA could be detected
in the giant organelles after 2.5 h of continuous uptake, but
the intensity of fluorescence increased with longer incuba-
tion times, up to 6 h of uptake or more. This finding was
verified by electron microscopy of BSA-colloidal gold uptake
by beige cells (Fig . 7) . After 20 min of uptake at 37°C, BSA-
gold particles were found in small (<0.4 jm in diameter)
endosomal vesicles, both in the cell periphery and in the
perinuclear region (not shown) . After 4 h of continuous up-
take, some BSA-gold particles were still located in these small
Figure 6 .
￿
Uptake offluorescent BSA into the giant organelles of beige
cells . A representative beige cell doubly labeled with endocytosed DTAF-
BSA and anti-1gp120 . Beige cells were incubated with DTAF-BSA for 3 h
at 37°C, and chased overnight . Theywere subsequently fixedand counter-
labeled with rat anti-1gp120 followed by Texas red goat anti-rat 1g. (A)
DTAF-BSA . (B) anti-1gp120. Arrowheads point to giant organelles filled
with BSA which also show membrane distribution of 1gp120 .
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Figure 7 .
￿
Electron microscopy ofBSA uptakeinto the giant organelles
of beige cells. Profile of a beige cell after 4 h ofuptake of colloidal gold-
BSA . Note the multivesicular ultrastructure ofthe giant organelle . (Arrow)
A small endosome, typical of the BSA containing structures found also
after 20 min of uptake .
early endosomes (Fig. 7, arrow) while others had reached
the giant perinuclear bodies (up to 4 p,m in diameter; Fig .
7) . These pleiomorphic organelles contained membranous
whorls and other material, and their structure was consis-
tent with that reported by others (1, 38, 39) . BSA-gold first
appeared in these giant organelles between 60 and 120 min
of uptake, consistent with transport to late endosomes and
lysosomes .
Incubation at 20°C has been shown to block transport of
internalized material from early endosomes into late endo-
somes and lysosomes (22) . When beige and CHS fibroblasts
were incubated with DTAF-BSA at 20°C instead of 37°C,
the tracer did not reach the giant organelles . Instead, the
DTAF-BSA remained in smaller, more dispersed structures
(Fig . 8) . By this operational criterion the giant organelles
function as late endocytic compartments . The distribution
ofDTAF-BSA at 20°C was the same as in the wild type con-
trol cells (not shown), indicating that there are no gross func-
tional abnormalities in early endosomes ofCHS and beige cells.
Taken together, these studies show that the giant clustered
organelles in beige and CHS cells are still active in endocytic
traffic of exogenous ligands, and are therefore on-pathway
structures. Traffic to the affected compartment is somewhat
slowed, but overall, it has the properties expected for traffic
to late endosomes and lysosomes .
TheMutant Cells Take Up andDegrade an Exogenous Ligand
Normally . To quantify the receptor-mediated uptake and
degradation of an exogenous ligand in the CHS and beige
cells we used iodinated a2-macroglobulin (cx2M) . This
serum protein binds, in a complex with proteases, to a sur-
face receptor present on fibroblasts, and their endocytic route
has been studied extensively (31) . '2 I-a2M was bound to the
cells at 4°C and then chased at 37°C for various times. Ascompared with their normal counterparts, CHS and beige
cells bound similar amounts ofa2M and internalized similar
amounts over a 4-h time course (data not shown) . a2M
degradation was measured as the appearance ofTCA soluble
counts in both the cell lysates and the media . Both beige and
CHS cells were capable of degrading the internalized a2M,
with neither mutant showing dramatic defects in compar-
ison to its matched control line (Fig. 9A) . Within individual
experiments, a small decrease in the extent of a2M degra-
dation was consistently observed in the beige cells, but this
difference was small relative to the variation among experi-
ments . To determine what portion of the measured degrada-
tion occurred in early and late endorytic compartments, cells
were allowed to internalize bound a2M for 3 h at either
20°C or 37°C . In both mutant and control cell lines, degra-
dation was blocked at 20"C (Fig. 9 B), indicating the re-
quirement for transport to late endorytic compartments, pre-
sumably including the giant organelles.
Discussion
One main finding of this study is that the abnormally en-
larged vesicles commonly observed in fibroblasts from both
beige mice and human patients with CHS are derived from
the late organelles of the endocytic pathway: mature secon
lysosomes and late endosomes. Previous reports had described
the giant structures as "lysosomes" because they take up neutral
red and endorytic tracers and contain acid phosphatase (e.g .,
[6, 8]), or because they lack specific lysosomal enzymes (39a) .
However, these criteria do not distinguish among the var-
ious compartments along the endocytic pathway . In this study
we usedmore precise markers and functional criteria to show
that the giant organelles are late endorytic compartments .
It is clear from our studies that early endosomal compart-
ments are not affected in either CHS or beige . First, trans-
ferrin receptor and rab 5, proteins found on the plasmamem-
brane and early endosomes, are not found on the giant
organelles . CI-MPR, which marks the same early endosomes
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Figure 8 .
￿
Effect ofreduced temperature on ar-
rival of endocytosed BSA at the giant organelles.
Beige or CHS cells were viewed after continuous
uptake of DTAF-BSA for 3-4 h at either 20°C or
37°C. Note that at 20°C DTAF-BSA is limited
to small endocytic vesicles throughout the
cytoplasm and is absent from the giant organelles.
as well as later endosomes, is also missing from the defective
organelles. Second, DTAF-BSA does not appear in abnormally
large structures until late times ofuptake, and at 20°C, where
movement between early and late endosomes is blocked, the
transfer of BSA to the giant organelles is blocked .
Marker analysis and functional studies both indicate that
the defects in CHS and beige are in late endorytic compart-
ments. The giant organelles contain acid phosphatase and
cathepsin D, hydrolases which are targeted by independent
mechanisms to late endosomes and lysosomes (16) . In addi-
tion, the defective compartment contains much of the cells'
lysosomal membrane glycoproteins (LAMPl/lgp-120 and
LAMP2) . These glycoproteins are present in both late endo-
somes and mature lysosomes, but are not present to any ap-
preciable extent in earlier endocytic compartments (40, 19,
20, 34) . The properties of tracer uptake are also character-
istic oflate endocytic compartments . The kinetics ofuptake
into the giant organelles and the sensitivity to reduced tem-
perature are similar to those found for transport into late en-
dosomes and lysosomes in wild type cells.
It is difficult to determine to what degree the CHS and
beige mutations selectively affect late endosomes vs. lysosomes.
Functional studies provide no clues, since conditions have not
been found that block exchange ofmaterial between the two
compartments, and since late endosomes are active in degra-
dation of proteins (41) . By electron microscopy, the giant
organelles resemble the complex membranous structure of
late endosomes more than the dense, spherical structure of
lysosomes . Marker proteins that are usually used to classify
the late endosomes and lysosomes give a somewhat mixed
picture. The giant organelles were negative for CI-MPR, as
expected for mature lysosomes, but some of them were posi-
tive for rab 7, which is a marker protein for late endosomes.
It is, of course, possible that the mutations cause selective
mislocalization of either CI-MPR or rab 7 . In this context,
it should also be noted that the presence ofCI-MPR in cer-
tain late endosomal/lysosomal structures is somewhat vari-
able. For example, phagolysosomes in macrophages sometimesFigure 9 .
￿
Degradation of a2M by beige and CHS cells. (A) Kinetics
of degradation. Plates of cells were pulsed with 1251-a2M at 4°C for 1 h,
washedextensively to remove unbound ligand, and then incubated for var-
ious times at 37°C . At the end of each chase time point, medium, and
cells were separated, and theTCA soluble and precipitable radioactivity
in each was determined . The percentage of the initial cell-bound radioac-
tivity which was converted to TCA soluble radioactivity is shown . The
results are expressed as means ± SE, derived from three-five independent
experiments with each of the four cell lines. Beige fibroblasts (filled squares) .
Wild type mouse fibroblasts (open squares) . CHS fibroblasts (filled circles) .
Wild type human fibroblasts (open circles). (B) Temperature dependence
of a2M degradation . Beige or wild type cells were pulsed with 1251-a2M
for 1 h at 4°C, washed, and then incubated for 3 h at either 4°C, 20°C,
or 37 °C. The percentages ofTCA soluble radioactivity at each tempera-
ture are shown . Beige (dotted ban) . Wild type (filled bars) .
contain CI-MPR (42) and sometimes lack both it and the
cation-dependent MPR (43) . In cytolytic lymphocytes that
contain late endosome-like lytic granules, these lytic granules
sometimes contain (8) and sometimes lack (44) CI-MPR,
and the distribution ofCI-MPR changes with the differenti-
ation of these lymphocytes (Griffiths, G ., S. Hester, J . Burk-
hardt, andY Argon, manuscript in preparation) . Such cases
preclude total reliance on the available markers and illustrate
the need for further criteria to distinguish between late en-
dosomes and lysosomes .
The appearance of the giant organelles is superficially
reminiscent of the selective "swelling" of this compartment
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in the presence of sucrose or other nondigestible carbohy-
drates (45) . Though the mechanism of giant organelle for-
mation in CHS is not known and in fact is often attributed
to excessive fusion (46, 47), the selective effect of the muta-
tion, like the selective effect of sucrose loading on late endo-
cytic compartments, underscores biochemical differences that
must exist between lysosomes and endosomes despite themany
common features of these endorytic compartments .
A second main conclusion ofthis study is that despite their
structural abnormality, the giant organelles are part of the
normal endorytic pathway. Exogenous ligands which enter
the cell either by fluid phase endocytosis (BSA), bulk mem-
brane retrieval (cationized ferritin ; data not shown), or
receptor-mediated endocytosis (a2M) all reach the giant lyso-
somes/late endosomes of the mutant fibroblasts . The uptake
into the giant vesicles is slow, however; more than 6 h are
required for substantial accumulation in this compartment
as compared to 3-4 h in wild type cells. Interestingly, nei-
ther the beige mutation nor theCHS lesion impairs the cells'
protein catabolic activity. The a2M employed as ligand here
is typical ofproteins that are taken up and degraded efficiently
in lysosomes (31) . In our hands, a2M degradation occurred
only at 37°C, both in normal and in mutant fibroblasts, in-
dicating that degradation required transport to a late endo-
cytic compartment . In the CHS cells, the degradation of
a2M was detectable only after more than 2 h of endocytosis,
but in beige significant degradation was measured already after
60 min. The extent ofa2M degradation we measured agrees
well with the degradation of a-glucosidase by CHS cells as
measured by Miller et al . (48) . It should be pointed out that
since there is considerable heterogeneity of late endosomal/
lysosomal organelles in both CHS and beige cells, it is pos-
sible that most of the degradation occurs in unaffected or-
ganelles, either late endosomes or small normal lysosomes .
However, our studies with the various tracers indicate that
a significant proportion ofendocytosed material is transported
to the giant organelles . Therefore, it is more likely that they
either function normally or equilibrate with a functional cata-
bolic compartment .
The normal catabolic activity of late endocytic compart-
ments in CHS and beige is consistent with the observation
that these organelles maintain a constant volume. In this re-
spect CHS differs from lysosomal storage diseases, where
defects in degradation of proteins or lipids often result in a
dramatic increase in the volume oflysosomes/late endosomes
(49) . Instead, the phenotype ofCHS and beige is more con-
sistent with a defect in fusion or fission oflate endocytic struc-
tures, which are now known to be highly dynamic, inter-
connected organelles (8, 33, 34) . Such a fusion defect is also
suggested by microscopic and histochemical observations of
polymorphonuclear lymphocytes (46), Langerhans cells (50),
and EBV-transformed cells (47) . Therefore, proteins that affect
fusion between specific membranes, such as small GTP-binding
proteins, are candidates for the gene products affected by the
CHS or beige mutations . Indeed, changes in the level of ex-
pression of rab proteins have been shown to affect the size
and cellular localization of the endocytic vesicles they associate
with, and overexpression of some rab proteins can generatelarge perinuclear organelles (51). Thus, it is of interest that
the distribution of rab 5, which associates specifically with
early endosomes (35), is the same in both the mutant and
control cells. Rab 7, which associates with late endosomes
(35), is present on some of the giant organelles, but other-
wise its distribution appears to be normal as well. So far,
no rabs have been identified that bind to mature lysosomes.
Given our qualitative results, it will be informative to test
the expression of other rab proteins in beige and CHS.
A third conclusion from our results is that the murinebeige
and the human CHS defects cannot be distinguished on the
basis of any of the criteria employed here. The distribution
of marker proteins, the acidity of the giant lysosomes, their
intracellular distribution, the uptake characteristics, and the
degradation ofligands are all affected similarly by the mouse
and human mutations. Our data therefore support the long-
held view that homologous genes are affected in beige and
CHS. Furthermore, our data suggest a number of assays that
can be used in genetic complementation studies, towards iden-
tifying the CHS gene.
One of the perplexing aspects of CHS is that secretory
granules are affected in some cell types such as granular leu-
kocytes, whileendocytic organelles are affected in other cells,
like the fibroblasts studied here. That these two types of or-
ganelles are affected by the same mutations indicates that they
have common components. Indeed, a number of similarities
have been observed between lysosomes and secretory granules.
Both are acidic organelles, and proteins designated to them
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